Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Panbela Therapeutics: Q1 Earnings Insights

Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Panbela Therapeutics missed estimated earnings by 8.0%, reporting an EPS of $-0.27 versus an estimate of $-0.25.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 1.42% drop in the share price the next day.

To track all earnings releases for Panbela Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Biogen Q3 Earnings

By Benzinga Insights
Today, 2:46 AM
Biogen (NASDAQ:BIIB) reported its Q3 earnings results on Tuesday, October 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Biogen beat estimated earnings by 14.66%, reporting an EPS of $4.77 versus an estimate of $4.16.

BIIB